EPZ 6438 companion diagnostic - Eisai/Epizyme/Roche
Latest Information Update: 30 Apr 2014
At a glance
- Originator Roche Molecular Systems
- Developer Eisai Co Ltd; Epizyme; Roche Molecular Systems
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Non-Hodgkin's lymphoma
Most Recent Events
- 07 Jan 2013 Clinical trials in Non-Hodgkin's lymphoma (diagnosis) in USA